A study to learn if UCB3101 is safe and how it moves through the body of healthy participants
This study is one of the very first times a medicine called UCB3101 is being given to people. It's a key first step in developing new treatments. The main goals are to check if UCB3101 is safe for healthy adults and to see how the medicine moves through and is processed by the body. This helps us understand what dose might be best and if there are any immediate concerns. By taking part, healthy volunteers help researchers gather important basic information about this new drug, which could eventually lead to new treatments for people who need them. This type of study uses healthy volunteers to carefully observe the effects of the new medicine in a controlled environment.
At a glance
What is this study about?
Imagine scientists are creating a brand new key and they need to see if it fits a lock. This study is similar. A new medicine, known for now as UCB3101, has been developed, and before it can ever be used to treat illnesses, we need to understand how it behaves in the human body. This particular study is the very first time UCB3101 will be given to people. It's a crucial first step in its journey to potentially becoming a useful treatment.
The main aim of this study is to discover two important things: first, if UCB3101 is safe for people to take, and second, how it travels through and is processed by the body. This could include how quickly the body absorbs it, how long it stays in the system, and how the body gets rid of it. Understanding these details is vital because it helps researchers work out what dose might be safe and effective in future studies for specific conditions.
By taking part, healthy volunteers play a really important role. The information gathered from this early research helps scientists build a complete picture of UCB3101's effects. It's a careful and monitored process designed to ensure that if the medicine moves to later stages of development, it's done so with the best possible safety knowledge. This gentle start helps pave the way for potential new treatments that could one day help many people.
Key takeaways
- This is a 'first-in-human' study for a new medicine called UCB3101.
- The main goals are to check for safety and how the medicine behaves in the body.
- Healthy adults (18 years and older) are needed as volunteers.
- Participation involves health checks, taking the medicine, and close monitoring.
- Your contribution helps advance medical science for potential future treatments.
Who may be eligible?
This study is looking for healthy adult volunteers. This means you should generally be in good health and not have any serious or ongoing medical conditions. The doctors will do health checks to make sure you are suitable for the study.
To join, you need to be at least 18 years old. There isn't an upper age limit, so adults of any age from 18 upwards can potentially take part, as long as they meet the other health criteria. The study welcomes both men and women to participate.
The research team will carry out a thorough health check to confirm you meet all the requirements for taking part. This ensures the safety of everyone involved and helps make sure the study results are as clear and accurate as possible.
- Are you generally healthy?
- Are you 18 years old or older?
- Do you not have any serious ongoing medical conditions?
- Are you willing to attend regular appointments for health checks?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you would first have a screening visit where doctors check your health and make sure you fit the study's requirements. This would involve a medical history, physical exam, and some basic tests. If you qualify, you would receive the study medicine, UCB3101. This is likely to happen at a special clinic or hospital, where you might stay for a short period so doctors can closely monitor you. You'll have regular checks, such as blood tests, heart rate monitoring, and blood pressure readings, to see how your body reacts to the medicine and how it moves through your system. There might be several visits over a period of time, including follow-up appointments after you've finished taking the medicine, to ensure your health is still good. The exact number and length of visits will be explained in full by the study team.
Potential risks and benefits
Locations (1)
- —Belgium
Common questions
What is UCB3101?
UCB3101 is a new potential medicine being tested for the very first time in people.
Why do healthy people take part in these studies?
Healthy volunteers help us learn how a new medicine works and if it's safe before it's given to people with an illness.
Will I get better if I take part?
This study is not designed to treat an illness, but to understand how a new medicine works in healthy people.
How long will the study last for me?
The full length of your participation, including visits and follow-ups, will be clearly explained by the study team.
Can I leave the study if I change my mind?
Yes, you can leave the study at any time, for any reason, and it won't affect your future medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.